A Multicenter, Randomized, Parallel-group Clinical Study on the Effects of Henagliflozin Proline Tablets and Metformin Sustained-release Tablets on Body Composition in Geriatric Patients With Newly Diagnosed Type 2 Diabetes Mellitus
Latest Information Update: 14 Jan 2026
At a glance
- Drugs Henagliflozin (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms HABIT-GEMs
Most Recent Events
- 14 Jan 2026 New trial record